Introduction {#Sec1}
============

It is well established that one of the mechanisms through which stress influences memory and cognition are elevations in cortisol level ([@CR62]). In healthy populations, investigations into chronic stress have shown that long term administration of GCs impairs declarative memory ([@CR70]; [@CR42]). The effects of *acute* stress on declarative memory have been investigated either by elevating cortisol levels with psychosocial stress ([@CR17]; [@CR2]; [@CR29]), or with one-off GC administration ([@CR1]; [@CR8]; [@CR26]; [@CR14]). In contrast to chronic studies, acute stress studies into effects of cortisol made it possible to disentangle the effects of GCs on encoding, consolidation and retrieval (see for a review on acute effects [@CR37]). [@CR14] were the first to target specific memory phases by pre-learning, post-learning and pre-retrieval administration of 25 mg of cortisone to healthy participants in a randomized crossover design. In their study, GCs administered 1 h before retrieval significantly impaired free recall of words learned 24 h earlier. The same dose given before or after learning had no effect on encoding or consolidation of words. In several psychosocial stress studies it was found that participants who showed a pronounced cortisol increase in response to the stressor performed poorer in memory retrieval compared to participants who only had a mild or no cortisol response, which suggests that the results obtained with GC administration are comparable to those with psychosocial stressors ([@CR65]; [@CR9]; [@CR26]).

Since the study of de [@CR14], several modulators of the effects of GCs on memory performance have been uncovered, such as dose (e.g., [@CR1]), gender ([@CR65]), age ([@CR63]; [@CR38]), and time of day ([@CR22]; [@CR39]). Also, arousal experienced during encoding ([@CR2]) and arousing properties of the declarative material itself ([@CR8]; [@CR64]) appeared to influence GC effects on memory performance. For instance, GC administration ([@CR31]) or stress ([@CR11]) is associated with enhanced memory *consolidation* of emotionally arousing material, but not of neutral material. In contrast, acute psychosocial stress is associated with greater impairments in memory *retrieval* of emotionally arousing than more neutral information ([@CR29]). Moreover, GC administration before retrieval lowered the tendency to recall emotional words better than neutral words ([@CR28]) (for a review on the opposing effects of GCs on consolidation and retrieval processes, see [@CR46]).

As of yet, it remains unclear how GCs exert their influence on memory in the human. Glucocorticoid receptors (GRs) have been found in several brain areas of relevance for memory, specifically the hippocampus and the PFC. On the basis of animal and human studies it has been proposed that the effects of GCs on cognitive functioning depend (at least in part) on activation of glucocorticoid receptors in the hippocampus ([@CR46]; [@CR47]) or the differential activation of mineralocorticoid and glucocorticoid receptors in the hippocampus and prefrontal cortex ([@CR44]; [@CR36]; [@CR38]). Cortisolrelated retrieval impairments usually appear during 'hippocampus-dependent' tasks that require conscious recollection of the study episode, such as free recall ([@CR9]; [@CR14]; [@CR28]) and cued recall tasks ([@CR13]). Occasionally, cortisol-related impairment in recognition memory has been reported ([@CR16]), which is considered to be partly recollection- and partly familiarity-based.

Apart from the hippocampus, the prefrontal cortex (PFC) plays a general role in retrieval of declarative memories. Recognition, cued recall and free recall of previously studied words have all shown to activate the PFC ([@CR10]). In addition, functional magnetic resonance imaging (fMRI) studies have consistently reported activation in both the medial temporal lobe and PFC during memory retrieval, and there is evidence of interactions between these brain regions during memory retrieval (for reviews see [@CR10]; [@CR52]). The PFC as well as the hippocampus are known to be significant targets of circulating glucocorticoids ([@CR36]). Moreover, cortisol-related impairment in prefrontal-dependent working memory tasks has been reported ([@CR35]; [@CR17]; [@CR70]; [@CR43]; [@CR63]). Therefore, apart from the hippocampus, GC-effects on the PFC could be expected during memory retrieval.

So far, one H~2~^15^O-positron emission tomography (PET) imaging study investigated the effects of GC administration on memory retrieval in young healthy men ([@CR13]). In that study, 25 mg cortisone impaired cued recall of neutral word pairs learned 24 h earlier and this was associated with reduced blood flow in the right parahippocampal gyrus, left visual cortex and cerebellum. Surprisingly, no cortisol-related changes were found in prefrontal brain regions. It is possible that the low temporal resolution of PET has masked the cortisol effects in the PFC: PET typically localizes sustained averaged activation during a 60--90 min window, and cannot compare brain activation patterns associated with specific events, such as correct and incorrect retrieval and correct rejections. These activations can be determined with event-related (ER)-fMRI.

To our knowledge, GC-effects on memory retrieval have never been localized using fMRI. The aim of the present study was to localize the differential effects of GC administration on retrieval of neutral and emotional words in young healthy men. Here we used ER-fMRI in a double blind placebo-controlled randomized crossover design during retrieval of words in a recognition paradigm. We expected to find a GC-induced decrease in the blood oxygen level dependent (BOLD) response in the hippocampus and PFC during correct retrieval of previously learned words compared to placebo conditions. In addition, we investigated whether treatment interacts with the arousing properties of the words by using negative emotional and neutral items.

Materials and methods {#Sec2}
=====================

Participants {#Sec3}
------------

Twenty-eight male university students volunteered to participate in this study. Screening led to the exclusion of six volunteers: four for medical or psychiatric reasons and two for left-handedness. One participant did not show up for the second scan session, leaving a total of 21 young (mean age: 22.8±2.9 years, mean BMI: 22.3±1.8), healthy, right-handed participants. Due to technical problems fMRI data of one participant were lost so that imaging data of 20 participants could be analysed, whereas data of 21 participants were available for behavioral analysis.

Participants gave written informed consents. All received 75 Euros for their participation. Criteria for inclusion were: a body mass index (BMI=kg/m^2^) between 18 and 25, no medical and psychiatric history, determined by a brief version of the Amsterdam Biographical Interview (ABV; [@CR61]) and the Dutch version of the Symptom Checklist-90 ([@CR3]), using norm scores for a healthy population. Exclusion criteria included use of medication or psychotropic drugs within three months prior to the test sessions, blood pressure over 140/90 mmHg, diabetes, current and past psychiatric problems, the use of remedies containing corticosteroids, and lefthandedness. Females were not included in this study to avoid interactions of hormones due to menstrual cycle or birth control pill and cortisol, or other specific sex differences in stress effects on memory ([@CR65]). The study was approved by the medical ethical committee of the Free University Medical Center (VUMC), and carried out according to the standards of the Declaration of Helsinki ([@CR12]).

Design {#Sec4}
------

In a double blind, randomised placebo-controlled crossover design, participants aged 19--28 years (mean age, 22.8±2.9) received 20 mg hydrocortisone (Hoechst) or placebo. With regard to the dose and timings, the design was very similar to the behavioural study of [@CR63], who found GC-induced retrieval impairments in delayed free recall. Tablets were ingested 1 h prior to scanning in order to achieve high cortisol levels. Cortisol level was monitored throughout the study using Salivettes ([@CR25]).

Recognition task {#Sec5}
----------------

The recognition task was adapted from a paradigm by de [@CR15]. During each scan session, the task consisted of an encoding-phase (outside the scanner) of 80 target words (40 emotional negative, e.g., terrorist, and 40 neutral, e.g., architect) and a recognition-phase (inside the scanner). Words were selected from a pool of words validated in a perceptual clarification task (Ter Laak, unpublished Master\'s thesis), in which these words were recognized most consistently and rapidly as neutral and negative words under minimal presentation conditions. This task was considered to be an intentional encoding task, because participants were casually informed that 'later on' they would be tested for word recall. Participants were instructed to view randomly presented words, and to indicate the emotional value of the word by pressing either '0' (*neutral*) or '1' (*emotional*) on a laptop keyboard. In the recognition-phase of the task, the 80 encoded targets were shown together with 80 foils (40 new emotional negative and 40 new neutral words), and 40 fillers. All stimuli were projected on a back-projection screen located at the head end of the scanner table via an LCD projector located outside the scanner room. Subjects viewed all stimuli on a screen through a mirror placed on the head coil.

Participants had to push a button as fast as possible to indicate whether they consciously recollected a given word from the learning phase ('remember'), whether they were less certain of having learned the word ('know'), or whether they had no recollection of the word ('not seen before'). Therefore, on each trial, one of the target words or foils was shown against a grey background, while response options were indicated at the bottom of the screen by black arrows pointing to the left and to the right ("⋘not seen \< know \> remember⋙"). Fillers consisted of the instruction '⋘press left button' or 'press right button⋙', and were used as baseline. After the response was made a 1--2 second inter-stimulus-interval (grey screen) started, from stimulus offset until stimulus onset. All stimuli were presented in a self-paced manner, in order to prevent distress or boredom of the participants, and to automatically induce jitter. A time limit of 3 s was maintained in case of non-responses. Four word lists were used, two for each session that contained emotional and neutral words matched for valence, frequency, and length. List order was balanced across participants, so that half of the participants had list 1 or 2 as targets and list 2 or 1 as foils during the first session, and list 3 and 4 as targets or foils at the second session. List 3 and 4 were administered to the other participants during their first session. Stimulus order within the lists was pseudo randomized. There was no significant effect of List Order (*p*=0.35).

MRI scanning {#Sec6}
------------

Imaging was carried out on a 1.5 T Sonata MR scanner (Siemens, Erlangen, Germany), using a standard circularly polarized head coil with foam padding to restrict head motion. In both scan sessions, a T1-weighted structural MRI-scan was obtained (repetition time 2700 ms, inversion time 950 ms, echo time 3.97 ms, flip angle 8°, 160 coronal slices, voxel size 1 × 1.5 × 1 mm^3^). For fMRI, gradient echo and echo planar images (EPI) sensitive to BOLD contrast were obtained in the axial direction (echo time 60 ms, flip angle 90°, isotropic voxels of 3.3 mm, 36 slices, repetition time 2.85 s). The scan procedure on both scan sessions consisted of a structural scan (10 min), echo planar imaging (EPI) during the recognition task (9--14 min), EPI to investigate resting states (10 min), and EPI during a picture encoding task (±12 min), (both EPI resting states and EPI picture encoding task data will be published elsewhere), and a high resolution gradient echo EPI scan (echo time 45 ms, flip angle 90°, 1.64×1.64×2.20 mm voxels, 64 slices) (0.5 min).

Procedure {#Sec7}
---------

Participants were invited to the VUMC on three occasions; two scan sessions, 2 weeks apart from each other, and a third time, 8 days after the last scan session. Participants had been asked to refrain from any caffeine or sugar containing drinks, and to have exactly the same light breakfast on both scan days. Furthermore, they were asked to refrain from food intake 2 h before each fMRI procedure. Participants were scanned at exactly the same time during the two appointments, somewhere between 1100 and 1400 h, to keep baseline cortisol levels for each participant as equal as possible. On both scan sessions, exactly the same procedure was followed. First, participants were seated in front of a laptop in a separate room for the encoding of wordlists. Next, they filled out the state-version of the State-Trait Anxiety Inventory (STAI) and were seated for an hour in a waiting room. Seventy-five minutes after arrival, 1 h after the word encoding (to prevent direct effects of pill-ingestion on consolidation), participants were given a tablet containing hydrocortisone 20 mg or a similar looking placebo. One hour after pill ingestion, recognition was tested in the scanner. Saliva was sampled four times on both scan sessions, immediately after arrival ('pre-baseline'), before pill ingestion ('baseline'), immediately before entering the scanner ('prescan'), and immediately after the scanning session ('postscan'). Participants filled out an exit-interview, and were paid and thanked for their participation.

Data analyses {#Sec8}
-------------

*Word task* Proportions of correct hits (CH), false rejections (FR) of old words, and False hits (FH) and correct rejections (CR) of new words ('foils') were calculated (total raw scores per category/(40)). Because the number of 'know' responses was small, these were categorized as CHs, since modelling these as events of no interest would have resulted in too few CHs in about half of our subjects. Old/new discrimination accuracy (D\') was calculated as P (CH)-P(FH) ([@CR54]). To check for order and learning effects, RTs of correct hits and rejections and proportion of correct and false hits were analysed separately with repeated measures ANOVAs with Treatment Order as between-subjects factor, and Session, Response Type (new vs. old words), Correctness of Response (correct vs. false hits) and Valence (emotional vs. neutral) as within-subjects.

Effects of Treatment on retrieval and discrimination accuracy were analyzed separately in 2 (treatment) × 2 (Valence \[neutral/emotional\]) repeated measures ANOVAs, all two-tailed, with proportions of hits (correct and false hits) and D' as dependent variables. Finally, RTs were analysed using a repeated measures ANOVA with Treatment, Hit Type (CH vs FH) and Valence as within-subjects factors.

Cortisol {#Sec9}
--------

Free cortisol levels in saliva were measured using a commercially available chemiluminescence assay kit (IBL, Hamburg, Germany). Both inter- and intra-assay variance was below 10%.

Results {#Sec10}
=======

Salivary cortisol levels {#Sec11}
------------------------

As expected, pre-baseline (mean±SD, hydrocortisone 16.1±9.5 nmol/l; placebo 15.1±8.8 nmol/l) and baseline values (mean±SD, hydrocortisone 9.23±7.1 nmol/l; placebo 7.7±4.2 nmol/l) did not differ (pre-baseline, *t*=0.32, *df*=40, *p*=0.75, two-tailed; baseline, *t*=0.87, *df*=40, *p*=0.39, two-tailed). Pre-scan (mean±SD, hydrocortisone 107.5±76.8 nmol/l; placebo 6.4±3.0 nmol/l) and post-scan values (mean±SD, hydrocortisone 72.6±46.4 nmol/l; placebo 9.1±6.2 nmol/l) were significantly higher in the hydrocortisone- condition than in the placebo-condition (prescan: *t*=5.88, *df*=19.06, *p*\<0.0005; postscan: *t*=6.22, *df*=20.74, *p*\<0.0005, equal variances not assumed for both *t*-tests). The McNemar test using binomial distribution showed that participants were not able to tell whether they had received placebo or hydrocortisone: four participants (out of 21) correctly indicated noticing an effect of hydrocortisone, whereas four others (out of 21) incorrectly noticed effects of placebo (*n*=21, exact *p*=1.00).

Behavioral results {#Sec12}
------------------

### Proportion of hits {#Sec13}

Mean proportions of hits (CHs and FHs) are shown in Table [1](#Tab1){ref-type="table"}. For correct hits, there was a significant effect of Session (*F*\[1, 19\]=4.59, *p*=0.045), with better performance during the second session, irrespective of treatment or group (CHs, session 1: *M*±*SE*=0.68±0.04; session 2: *M*±*SE*=0.76±0.03). There was a trend towards a significant between-subjects effect of Treatment Order (*F*\[1, 19\]=3.41, *p*=0.08, with the group that had placebo first performing less well than the group that received hydrocortisone first (CHs: placebo first, *M*±*SE*=0.67±0.04, vs. hydrocortisone first, *M*±*SE*=0.78±0.04), on recall of emotional words on session 1 only (see supplementary analyses). For false hits there was no significant between-subjects effect of Treatment Order, and no Session by Treatment Order interaction, both *p*s\>0.22. Table 1Recognition performanceProbabilityReaction timesTreatmentCHFHCHFHCR*MMMMM*(*SEM*)(*SEM*)(*SEM*)(*SEM*){*SEM*)CortisolEmo0.820.501,374.851,643.521,464.78(0.03)(0.05)(81.64)(101.41)(78.79)Neu0.660.261,534.341,839.431,426.43(0.04)(0.04)(112.39)(125.77)(74.87)PlaceboEmo0.770.451,478.941,884.141,625.45(0.05)(0.05)(76.39)(112.18)(77.21)Neu0.650.261,593.061,875.521,520.64(0.05)(0.05)(99.16)(107.11)(79.19)Mean probability of hits (and standard error), expressed in proportions, and mean reaction times (and standard error) in both cortisol and placebo condition. *CH* correct hits, *FH* false hits, *CR* correct rejections, *Emo* emotional words, *Neu* neutral words.

When analyzing treatment effects, no within-subjects effect of Treatment on correct and false hits was found (*p*s \>0.24). A within-subjects effect of Valence showed that emotional words were more often categorized as previously presented compared to neutral words, regardless of whether the word was old (correct hits, *F* \[1, 20\]=22.57, *p*\<0.0005) or new (false hits, *F* \[1, 20\]=152.74, *p*\<0.0005). There was no main effect of treatment on discrimination accuracy (*p*=0.74). Discrimination accuracy of emotional words tended to be lower than of neutral words (*F* \[1, 20\]=3.60, *p*=0.07). No Treatment by Valence interaction emerged on correct and false hits or discrimination accuracy (*p*s\>0.3).

Reaction times {#Sec14}
--------------

Mean reaction times (RTs) are shown in Table [1](#Tab1){ref-type="table"}. No between-subjects effect of Treatment Order was found, *F* (1, 14)=0.01, *p*=0.92. However, there was a significant main effect of Time (*F* \[1, 14\]=15.37, *p*=0.002): Both groups responded significantly faster during the second session, possibly due to practice. The group that first had placebo was slower on its first session and faster on the second session compared to the group that had hydrocortisone first, an effect that was also reflected by the analyses of the proportion of hits.

The RT data (CHs and CRs) were further analyzed for treatment effects on separate sessions. Although mean scores in the Hydrocortisone condition show faster responses than the Placebo condition, separate ANOVAs of the RTs on separate sessions showed that this was not a significant effect of Treatment (Session 1: *F* (1, 18)=0.65, *p*=0.43; Session 2: *F* (1, 19)=0.55, *p*=0.47).

fMRI results {#Sec15}
------------

### Placebo {#Sec16}

Left prefrontal and left parietal regions were significantly activated during correct retrieval (CH-CR) (see Table [2](#Tab2){ref-type="table"}). These regions are typically activated during successful episodic memory retrieval ([@CR27]; [@CR10]). Activation was also found in the right hippocampus. Separate analyses for neutral and emotional words demonstrated that mainly neutral words accounted for these effects (see Fig. [1a](#Fig1){ref-type="fig"} for activations with *z*\>3.1, uncorrected *p*). Since there were no activations associated with presentation of the emotional words, we left this contrast out of further analyses. Fig. 1The contrast neutral correct hits vs. neutral correct rejections **a** showing areas active during placebo treatment, thresholded z value of 3.1 for display purposes; **b** showing activity during cortisol treatment (*z*\>3.1), see Table [2](#Tab2){ref-type="table"} for those maxima of clusters that survived cluster-correction; and c showing areas in the superior frontal gyrus, putamen and precuneus in which activity was significantly decreased during hydrocortisone as compared with placebo treatment (cluster-corrected *z*\>3.1, *p*\<0.05). The *up-per and lower horizontal slices* correspond to resp. *z*=34 and *z*=57 in the Talairach coordinate system ([@CR57]). *Left in the image* is left in the brainTable 2Maxima of regions showing significant (*p*\<0.05, clustercorrected) during successful retrievalRegion of activationLeft/RightBAx, y, z (mm)*Z* valuePlacebo*CH-CR*Superior frontal gyrusL10−2668−24.66Inferior parietal lobeL40−48−50564.64Medial frontal gyrusL9−436284.53PrecuneusL7−2−74444.50Caudate nucleusL−101024.24Cingulate gyrusL23−2−16323.85HippocampusR16−4−122.38^1^*Neu CH- Neu CR*Midfrontal gyrusL9−4622304.41Superior frontal gyrusL10−226604.61Inferior parietal lobeL40−48−52584.70Medial frontal gyrusL9−436284.26PrecuneusL7−4−72424.14Caudate nucleusL−121024.54HippocampusR34−24−102.49^1^Cortisol*CH-CR*Superior parietal lobeL7−44−62544.89Midfrontal gyrusL9/46−4824283.97Midfrontal gyrusL10/47−4256−43.97*Neu CH-NeuCR*Superior parietal lobeL7−46−62544.73Midfrontal gyrusL9/46−5026263.82Midfrontal gyrusL10/47−4456−44.09Cortisol \< Placebo*CH-CR*HippocampusR16−4−122.71^1^*Neu CH-Neu CR*Superior frontal gyrusR102466−043.64PutamenL−1610−063.37PrecuneusR712−76463.50HippocampusL−26−20−142.73^1^HippocampusR34−24−102.67^1^*CH-CR* correct hits ("old") contrasted with correct rejections ("new") of the pooled words, *NeuCH-NeuCR* correct hits contrasted with correct rejections of neutral words, *BA* Brodmann area, *x*, *y*, *z* coordinates of local maxima are listed according to the Talairach coordinate system ([@CR57]).^1^ Uncorrected *p*\<0.01

### Hydrocortisone {#Sec17}

Significant brain activity during successful retrieval of all old words (CHs vs. CRs) was found in the left superior parietal lobe and left midfrontal gyri during hydrocortisone treatment (see Table [2](#Tab2){ref-type="table"}). This was entirely attributable to the activation associated with retrieval of neutral words (NeuCH vs. NeuCR) (see Fig. [1b](#Fig1){ref-type="fig"}).

### Treatment effects {#Sec18}

Relative to placebo condition, in the contrast CH-CR (pooled words) hydrocortisone treatment led to significantly less activation in the right hippocampus (Table [2](#Tab2){ref-type="table"}). When neutral words were analyzed separately (neuCH-neuCR), significantly less activation was found during hydrocortisone treatment in the right superior frontal gyrus, left putamen and right precuneus compared to the placebo condition (see Fig. [1c](#Fig1){ref-type="fig"}). In addition, significantly less activation was found bilaterally in the hippocampus during hydrocortisone treatment compared to placebo condition (see Fig. [2](#Fig2){ref-type="fig"}).

![Coronal slices showing significant hydrocortisone-induced decreases in activation as compared with placebo in left and right hippocampus (*z*\>2.3, uncorrected *p*). *Left in the image* is left in the brain](11682_2007_Article_9003_Fig2){#Fig2}

Discussion {#Sec19}
==========

In the present study for the first time GC-induced decreases in brain activity during successful declarative memory retrieval were localized using ER-fMRI. Under placebo conditions, robust activations showed up during successful retrieval in areas consistently found as part of an episodic retrieval network, including hippocampus, left parietal and predominantly left prefrontal areas ([@CR27]; [@CR59]; [@CR10]; [@CR51]). Consistent with our hypothesis, GC administration reduced brain activation in both the PFC and hippocampus. Although a lenient criterion for finding decreases in hippocampal activation was used, our data converge with [@CR13], who found support for right MTL involvement in mediating cortisol effects on declarative memory retrieval which increases the validity of our data. These findings are consistent with the view that GCs may affect declarative memory retrieval through mediation by both hippocampus and PFC ([@CR36]). The present data extend the results of de [@CR13].

Declarative memory is known to rely on the integrity of the hippocampus. However, the PFC is also involved with declarative memory retrieval ([@CR33]) irrespective of whether task type is free recall, cued recall or recognition ([@CR10]). Furthermore, MTL and PFC are known to interact during retrieval ([@CR52]). The PFC as well as the hippocampus are known to be significant targets of circulating glucocorticoids ([@CR36]). In addition, GC-associated memory impairments on a behavioural level are well established. For instance, [@CR63] found GC-induced impairments of free recall of neutral words in a design similar to the present study. Clearly, complex effortful retrieval, such as free recall, makes greater demands on processes of organization, strategic search, monitoring and verification, relative to more automatic remembering like recognition. The interactions between frontal and temporal regions may therefore be more important in effortful tasks, such as free recall ([@CR52]), making it more sensitive to the effects of GCs on a behavioral level. Nonetheless, because the participants in our study hardly ever gave 'know' answers, our task mainly tapped from the recollective aspects ('remember') of recognition, that appear to depend more on (the integrity of) the hippocampus, than the familiarity components ('know') of recognition (see for a review ([@CR7]). Unfortunately, the number of 'know' answers was too small for separate analyses, so we could not differentiate between 'remember' and 'know' components. Nevertheless, since both the hippocampus and PFC were affected by GCs in this study, it is likely that in more demanding tasks reduced activation in the PFC will be associated with GC-induced retrieval impairments. Free recall protocols fit for fMRI or the use of more difficult (associative) recognition tasks would be a promising direction for further replication of behavioural studies.

Apart from decreases in activation in MTL and PFC, reduced activation during successful retrieval was also found in the precuneus and putamen. The parietal lobe has also found to contribute to declarative memory retrieval ([@CR51]; [@CR34]). It has been suggested that frontal and parietal regions provide a general signal of retrieval success, probably by indicating that information is 'old' ([@CR10]), or perceived as 'old' ([@CR60]). The posterior parietal cortex and precuneus might contribute to retrieval through its connections to the MTL ([@CR59]). Perhaps, the reduction in activation of the precuneus that we have found is a consequence of decreased activity in the hippocampus, or it could be a direct effect of GCs on the precuneus. Since working memory is dependent on prefrontal and parietal regions our findings may also be relevant in understanding the acute impairing effects of high cortisol levels on working memory ([@CR35]).

Several limitations of the present study should be noted as well when interpreting the present findings. First, no treatment effects on task performance were found. Although the study had sufficient power to detect differences in brain activation between hydrocortisone and placebo treatment, no differences were found in recognition memory performance. This could be explained by the number of participants in our study. The only (behavioral) study that has reported cortisol-induced retrieval impairments in recognition memory included 60 male participants ([@CR16]), which is far more than the number of participants in our study. Also, as stated before, the effects of cortisol on a behavioural level may be stronger in more demanding memory tasks, such as free recall. Furthermore, we used intentional encoding (the participants consciously knew that they had to recall the words later on and possibly elaborated words deeper), instead of incidental encoding (so that participants are unaware at the time of encoding that they have to recall words later). With our design we had to keep sessions similar, and therefore we were not able to do the incidental encoding, which is often used in retrieval studies. Moreover, the present study was limited by an effect of order. This order effect appeared to be caused by deviating emotional word retrieval data on the first session of the group that had placebo on the first session. Only on the second session numerically less emotional words were recognized in the hydrocortisoneas compared with the placebo condition, which was in the direction of our expectations even though this was not a significant difference. Future memory retrieval studies should be aware of order effects in crossover designs and should consider including a third (control) group with two placebo conditions.

This study could also not provide information about the differential effects of GCs on neutral and emotional declarative memory, since the results with regard to the emotional words were difficult to interpret. What we can conclude is that we did find indications for reduced neural activation in the neutral category, which is in line with other studies that found an association between cortisol and impaired retrieval of neutral material ([@CR13]; [@CR14]; [@CR63]). With regard to the emotional category, [@CR15], who used a similar word recognition task and the same contrasts, also found that it looked like emotional stimuli recruited less cortical networks than emotional stimuli. However, by using the subtraction method in fMRI analyses the effects of emotional stimuli may have been cancelled out. Affective valence does have an effect on the tendency to respond 'old' to new emotional items, so that even when participants correctly identify new emotional items, brain activation resembling activity to old items may have been elicited. Also in an event-related potential (ERP) study differences in magnitude of the old/new effect for negative and neutral words were found, that were attributable to the increased positivity of the ERPs elicited by new negative items relative to the new neutral items ([@CR40]). Taken together, with the old/new effect it could not be clearly determined to what extent emotional stimuli had activated the retrieval network, and consequently the effect of hydrocortisone on emotional retrieval remains to be resolved. Clearly, more fMRI studies that use other paradigms are necessary to investigate the effects of GCs on emotional memory retrieval (see for instance [@CR56]).

So far, only a small number of studies have been published on the interaction of cortisol and stimuli with different valence or arousal properties. In one study GCs were administered before memory retrieval testing in female participants only ([@CR28]), and it was found that cortisol diminished the advantage of better remembrance that emotional words generally have. Our behavioural data cannot be directly compared to that study, however, since cortisol administration may have a very different effect in males than in females, as sex-steroids greatly influence the response to cortisol administration ([@CR30]; [@CR65]), and also because men and women respond differently to emotional stimuli ([@CR69]). Therefore, studies that include both men and women should be conducted. Other studies examined the effects of cortisol elevations during memory retrieval induced by psychosocial stress ([@CR29]; [@CR16]; [@CR43]). [@CR16] found that cortisol impaired recognition of emotionally arousing *positive* words, whereas the other two studies found cortisol-induced impaired memory for emotionally *negative* stimuli. Direct comparisons between stress-induced cortisol and cortisol administration are problematic for several reasons, however. For instance, results in stress-studies could be related to adrenergic mechanisms that may act in concert with GCs ([@CR47]; [@CR48]; [@CR41]). Human studies need to be performed to further clarify these putative interacting mechanisms.

This line of research may provide important data regarding the processing of traumatic memories or memory dysfunction in stress-related psychiatric disorders. There are indications that GCs could lessen traumatic memory retrieval, and as such, be useful to PTSD treatment ([@CR50]). In patients who have experienced traumatic stress, alterations in the hypothalamic-pituitary-adrenal axis, changes in hippocampal function and structure and associated declarative (hippocampus-dependent) memory deficits, have been found repeatedly ([@CR4]). There are also indications that patients with posttraumatic stress disorder (PTSD) have altered central brain sensitivity to glucocorticoids (GCs, cortisol in humans) with healthy individuals ([@CR21]; [@CR58] but see [@CR6]; [@CR5]). Moreover, cortisol administration has found to impair phobic fear memories ([@CR55]). Because noradrenergic mechanisms are also implicated in --- for instance --- PTSD and depression, future studies should incorporate noradrenergic measures to elucidate the interactions between noradrenergic and GC effects, and be aware of possible habituation within crossover designs ([@CR45]; [@CR32]).

To summarize, using fMRI we show for the first time in the human that acute cortisol elevation is associated with decreased brain activity in the PFC and hippocampus during declarative memory retrieval. This observation is in line with previous animal studies as well as behavioral human studies. The finding of differential effects on emotional material awaits further research. The in vivo localization of the effects of this key stress hormone in the human brain opens up an important new avenue for research in cognitive neuroscience, which ultimately should lead to a better understanding of stress associated psychiatric disorders.
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